Hartz, A.; Li, L.; Rejeski, H.A.; Pepeldjiyska, E.; Rackl, E.; Baudrexler, T.; Bojko, P.; Schmohl, J.; Rank, A.; Schmid, C.;
et al. Treatment of Leukemic Blood Samples with Granulocyte-Macrophage-Colony-Stimulating-Factor Combined with Prostaglandin E1 Is Associated with Reduced Frequencies of Tolerogenic Dendritic Cells and Increased Cytotoxicity Against Autologous Blasts. Biomedicines 2026, 14, 1279.
https://doi.org/10.3390/biomedicines14061279
AMA Style
Hartz A, Li L, Rejeski HA, Pepeldjiyska E, Rackl E, Baudrexler T, Bojko P, Schmohl J, Rank A, Schmid C,
et al. Treatment of Leukemic Blood Samples with Granulocyte-Macrophage-Colony-Stimulating-Factor Combined with Prostaglandin E1 Is Associated with Reduced Frequencies of Tolerogenic Dendritic Cells and Increased Cytotoxicity Against Autologous Blasts. Biomedicines. 2026; 14(6):1279.
https://doi.org/10.3390/biomedicines14061279
Chicago/Turabian Style
Hartz, Anne, Lin Li, Hazal Aslan Rejeski, Elena Pepeldjiyska, Elias Rackl, Tobias Baudrexler, Peter Bojko, Jörg Schmohl, Andreas Rank, Christoph Schmid,
and et al. 2026. "Treatment of Leukemic Blood Samples with Granulocyte-Macrophage-Colony-Stimulating-Factor Combined with Prostaglandin E1 Is Associated with Reduced Frequencies of Tolerogenic Dendritic Cells and Increased Cytotoxicity Against Autologous Blasts" Biomedicines 14, no. 6: 1279.
https://doi.org/10.3390/biomedicines14061279
APA Style
Hartz, A., Li, L., Rejeski, H. A., Pepeldjiyska, E., Rackl, E., Baudrexler, T., Bojko, P., Schmohl, J., Rank, A., Schmid, C., & Schmetzer, H.
(2026). Treatment of Leukemic Blood Samples with Granulocyte-Macrophage-Colony-Stimulating-Factor Combined with Prostaglandin E1 Is Associated with Reduced Frequencies of Tolerogenic Dendritic Cells and Increased Cytotoxicity Against Autologous Blasts. Biomedicines, 14(6), 1279.
https://doi.org/10.3390/biomedicines14061279
